Rinaman, Motor disturbances/hypoactivity Another concern with therapies targeting the mesolimbic system is that the behavioral outcomes obtained are not specific to ingestive behavior and mediated via a general increase or decrease in physical activity
Patients were randomized to liraglutide injection once-daily or placebo once-daily in combination with metformin with or without basal insulin treatment
With proper guidance from a health care provider, exercise becomes a powerful tool that enhances GLP-1 results while supporting independence, confidence, and healthy aging
Our team understands how GLP-1 drugs work, why they cause gastroparesis, and how to prove Novo Nordisk failed to warn patients adequately about the drugs risks
Remember, whether youre injecting insulin for the first time, running into problems, or just have questions, turn to your healthcare team for advice and instruction